InMed Pharmaceuticals (INM) Work In Process (2022 - 2025)
InMed Pharmaceuticals' (INM) quarterly Work In Process came in at $569262.0 in Q4 2025, up 122.37% year-on-year from $255992.0 in Q4 2024, and up 34.64% quarter-over-quarter from $422798.0 in Q3 2025.
InMed Pharmaceuticals (INM) Work In Process (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $569262.0 for Q4 2025.
- On a quarterly basis, Work In Process rose 122.37% year-over-year to $569262.0 in Q4 2025; TTM through Dec 2025 was $569262.0, a 122.37% increase from a year earlier, with the FY2025 full-year figure at $26695.0, down 13.38% from the prior year.
- Work In Process climbed to $569262.0 in Q4 2025 per INM's latest filing, from $422798.0 in the prior quarter.
- Across five years, Work In Process topped out at $1.7 million in Q2 2022 and bottomed at $18446.0 in Q3 2024.
- The 4-year median for Work In Process is $373256.0 (2025), against an average of $424701.1.
- Across the five-year window, Work In Process sank 94.01% in 2024 and jumped 2192.09% in 2025, its largest moves.
- Year by year, Work In Process stood at $798813.0 in 2022, then plunged by 76.59% to $186980.0 in 2023, then soared by 36.91% to $255992.0 in 2024, then soared by 122.37% to $569262.0 in 2025.
- Per Business Quant, the three latest INM Work In Process figures stand at $569262.0 (Q4 2025), $422798.0 (Q3 2025), and $26695.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 569,262.00 |
| Sep 30, 2025 | 422,798.00 |
| Jun 30, 2025 | 26,695.00 |
| Mar 31, 2025 | 323,714.00 |
| Dec 31, 2024 | 255,992.00 |
| Sep 30, 2024 | 18,446.00 |
| Jun 30, 2024 | 30,817.00 |
| Mar 31, 2024 | 439,086.00 |
| Dec 31, 2023 | 186,980.00 |
| Sep 30, 2023 | 85,655.00 |
| Jun 30, 2023 | 514,113.00 |
| Mar 31, 2023 | 548,593.00 |
| Dec 31, 2022 | 798,813.00 |
| Jun 30, 2022 | 1.72 Mn |